Real-time enrollment status for this breast carcinoma clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 10:05 PM UTC
| NCT Number | NCT06915168 |
| Recruiting Status | Recruiting |
| Condition | Breast Carcinoma |
| Phase | NA |
| Target Enrollment | 20 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Michigan Rogel Cancer Center |
| Last Updated on CT.gov | April 8, 2026 (Apr 8, 2026) |
As of July 18, 2026: Clinical trial NCT06915168 is currently recruiting participants. This na study for breast carcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Michigan Rogel Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06915168 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06915168 was last updated Apr 8, 2026 (April 8, 2026). HelloStudys verifies this status automatically.